Want to know the biggest Cardiovascular Trials in 2024 and how they will impact clinical practice? Listen to me on two PARALLAX podcasts with Ankur Kalra. We take a deep dive into the major hotline sessions of the biggest Cardiology conferences. Take a listen & share thoughts!
Sukh Nijjer
@SukhNijjer
Consultant Cardiologist FRCP PhD; Interventionalist; Hon Senior Clinical Lecturer Imperial College. Former RSM Cardiology President. Views own.
534 Following 4.4K Followers 7.7K Posts
Latest posts 5
Had a great time on the #Parallax #Podcast with @AnkurKalraMD from @radcliffeCARDIO. In person podcasting with no script and chocolate to fuel! Let us know your thoughts and what studies you felt were important
Parallax 🌟 What are the most impactful #CV trials of 2023?View quoted post on X
🎙️Dr @AnkurKalraMD & Dr @SukhNijjer reunite for an insightful end-of-year review:
#ORBITA-2 #FIRE #DAPA-MI #ILUMIEN IV #OCTOBER #ARTESIA #SELECT
🎥👉 ow.ly/OQKl50Qpf5X
#CardioTwitter #MedEd
Another great day at #HeartLive by @ford1102 & @sanjaysastry and honoured to be invited to do a live case with old friend & colleague @hussaincontrac8 at @WythenshaweHosp. Great case with multi-vessel disease needing multi-modal imaging, IVL and stent-like result with DEB.
A real pleasure to join some of the brightest minds in UK Cardiology as they competed for the RSM @RoySocMed Cardiology President’s Prize. Great work from all the speakers including @arunsau_ @DoctorMitShah @drgeorgejoy @DrKiranPatel1 @DrAdamHartley. Congrats to @rajkumar_chris
Great to see this presented & published @ziadalinyc. Elegant analysis @hect2701 - very pertinent points. What were thoughts on the increased coronary perforation in the OCT arm. I counted around 25 (0.2%) vs 0? Is this a result of pursuing EEL based stent expansion measures?
#ESCCongress @escardio @ESC_President @EAPCIPresidentView quoted post on X
ILUMIEN IV Results presented by @ziadalinyc
Simultaneously published @nejm
nejm.org/doi/full/10.10…
🔅Co-primary endpoints:
1 )post-PCI MSA
2) 2-year rate of TVF, defined as a composite of cardiac death, TVMI or IDR
🔅2,487 patients: 1,233 OCT-guided PCI & 1,254 angio-guided PCI.
Mean age 65.6 yr & 22.6% women. MSA in OCT-guided vs angio-guided group (5.72 ± 2.04 vs. 5.36 ± 1.87 mm2)
🔅TVF 7.4% vs. 8.2%;p=0.45
🔅OCT-guided PCI led to a larger MSA w 2/3 ⬇️ ST.
No ⬇️in 2-year rate of TVF given low and nearly identical rate of TVR
@nicolasamabile @twj1974 @cardioPCImom @RSohnMD @MaeharaAkiko @mmamas1973 @agtruesdell @NievesGonzalo1 @DrNataliaP @MogneeA @adityadoc1 @SripalBangalore @Steph_Achenbach @SrihariNaiduMD @SukhNijjer @nadia_sutton